Jerry Mercado, MD
Pediatrics · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mercado’s office at (408) 377-8100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A105688 · Current
Licensed to practise in California · since 2008 · expires 2028-07-31 · Far Eastern University, Dr. Nicanor Reyes Medical Foundation.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$54,985 in 2024
Medicaid paid $54,985 for 5,495 billed services this clinician did in 2024, up to 263 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 209 | $9,332 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 318 | $8,746 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 332 | $7,997 |
| Service | 117 | $5,035 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 577 | $4,602 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 416 | $2,984 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 410 | $2,954 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 318 | $2,280 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 285 | $2,111 |
| Pure tone audiometry (threshold); air only | 311 | $2,003 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 218 | $1,567 |
| 1ST HOSP IP/OBS HIGH 75 | 81 | $1,330 |
| 2024 | 5,495 | 25 | 263 | $54,985 |
| 2023 | 9,742 | 33 | 205 | $129,557 |
| 2022 | 7,386 | 27 | 181 | $88,121 |
| 2021 | 6,912 | 22 | 240 | $91,632 |
| 2020 | 5,745 | 20 | 258 | $76,412 |
| 2019 | 4,899 | 23 | 177 | $59,355 |
| 2018 | 5,059 | 25 | 143 | $132,997 |
See the largest Medicaid services in earlier years
2023
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 682 | $22,300 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 619 | $19,650 |
| Developmental screening | 254 | $13,208 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 222 | $8,218 |
| Pure tone audiometry (threshold); air only | 658 | $7,670 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 164 | $7,496 |
| Service | 163 | $7,014 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 847 | $6,988 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 520 | $5,170 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 640 | $4,982 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 633 | $4,913 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 504 | $3,930 |
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 608 | $20,239 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 454 | $14,251 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 169 | $7,869 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 210 | $7,541 |
| Pure tone audiometry (threshold); air only | 628 | $7,173 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 658 | $5,534 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 490 | $4,836 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 458 | $3,688 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 460 | $3,669 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 358 | $2,875 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 337 | $2,677 |
| Service | 47 | $2,022 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 567 | $18,508 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 302 | $14,085 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 389 | $11,967 |
| Pure tone audiometry (threshold); air only | 764 | $8,562 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 238 | $8,460 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 791 | $6,507 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 591 | $5,885 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 412 | $3,302 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 408 | $3,273 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 305 | $2,410 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 278 | $2,172 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 245 | $1,994 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 390 | $11,500 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 357 | $11,399 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 225 | $10,518 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 221 | $8,508 |
| Pure tone audiometry (threshold); air only | 672 | $7,740 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 915 | $6,895 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 517 | $5,160 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 387 | $3,026 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 381 | $3,016 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 299 | $2,430 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 256 | $2,192 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 200 | $1,389 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 183 | $8,584 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 279 | $8,285 |
| Clinic visit/encounter, all-inclusive | 67 | $7,365 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 183 | $6,816 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 224 | $6,082 |
| Pure tone audiometry (threshold); air only | 511 | $5,845 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 405 | $4,045 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 407 | $3,482 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 246 | $1,736 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 230 | $1,637 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 195 | $1,428 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 122 | $893 |
2018
| Clinic visit/encounter, all-inclusive | 838 | $84,866 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 194 | $10,456 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 173 | $7,619 |
| Pure tone audiometry (threshold); air only | 669 | $7,310 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 183 | $6,343 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 423 | $4,220 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 128 | $3,634 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 383 | $3,012 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years) | 24 | $1,160 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 125 | $923 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 107 | $883 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use | 97 | $700 |
Money from drug and device companies
$409 in 2025
| 2025 | 6 | 13 | None | $409 |
| 2024 | 7 | 14 | None | $391 |
| 2023 | 6 | 17 | None | $617 |
| 2022 | 3 | 5 | None | $203 |
| 2021 | 4 | 8 | None | $179 |
| 2020 | 4 | 9 | None | $188 |
| 2019 | 3 | 4 | None | $76 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Penmenvy | $219 | 5 payments
|
| Merck Sharp & Dohme | Rotateq | $65 | 2 payments
|
| Pfizer | Prevnar 20 | $36 | 2 payments
|
| Cranial Technologies | Doc Band | $33 | 2 payments
|
| Sanofi Pasteur | Beyfortus | $33 | 1 payment
|
| Seqirus USA | Flucelvax | $22 | 1 payment
|
See all 13 published payments
| GlaxoSmithKline | Meals · 2025-12-10 | Penmenvy | $24 |
| GlaxoSmithKline | Meals · 2025-09-16 | Penmenvy | $122 |
| GlaxoSmithKline | Meals · 2025-09-03 | Penmenvy | $24 |
| Pfizer | Meals · 2025-07-31 | Prevnar 20 | $14 |
| Merck Sharp & Dohme | Meals · 2025-07-30 | Rotateq | $38 |
| Cranial Technologies | Meals · 2025-07-15 | Doc Band | $17 |
| GlaxoSmithKline | Meals · 2025-06-18 | Bexsero | $21 |
| Cranial Technologies | Meals · 2025-04-30 | Doc Band | $16 |
| Pfizer | Meals · 2025-04-23 | Prevnar 20 | $22 |
| Merck Sharp & Dohme | Meals · 2025-03-12 | Rotateq | $27 |
| Sanofi Pasteur | Meals · 2025-03-03 | Beyfortus | $33 |
| GlaxoSmithKline | Meals · 2025-02-19 | Bexsero | $28 |
| Seqirus USA | Meals · 2025-01-15 | Flucelvax | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $391
| Merck Sharp & Dohme | Gardasil | $93 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $91 | 1 payment
|
| Pfizer | Prevnar 20 | $75 | 4 payments
|
| GlaxoSmithKline | Bexsero | $72 | 3 payments
|
| Sanofi Pasteur | Beyfortus | $26 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $20 | 1 payment
|
| Boston Scientific | Eluvia | $13 | 1 payment
|
2023: $617
| Abbott Laboratories | None | $197 | 1 payment
|
| GlaxoSmithKline | Bexsero | $190 | 4 payments
|
| Cranial Technologies | Doc Band | $84 | 7 payments
|
| Pfizer | Prevnar 20 | $60 | 3 payments
|
| Boston Scientific | None | $53 | 1 payment
|
| Merck Sharp & Dohme | M-M-R II | $34 | 1 payment
|
2022: $203
| GlaxoSmithKline | Bexsero | $135 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $48 | 2 payments
|
| Sanofi Pasteur | Menquadfi | $20 | 1 payment
|
2021: $179
| GlaxoSmithKline | Bexsero | $96 | 4 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $39 | 2 payments
|
| AbbVie | Lupron Depot | $28 | 1 payment
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
2020: $188
| GlaxoSmithKline | Bexsero | $88 | 4 payments
|
| Cranial Technologies | Doc Band | $47 | 3 payments
|
| Pfizer | Prevnar 13 | $32 | 1 payment
|
| AbbVie | Lupron Depot | $21 | 1 payment
|
2019: $76
| Merck Sharp & Dohme | Rotateq | $32 | 2 payments
|
| Teleflex | Catheter - Turnpike | $26 | 1 payment
|
| GlaxoSmithKline | Pediarix | $18 | 1 payment
|
Professional record
- NPI
- 1023296548
- Licence
- CA A105688California A105688: Current · expires 2028-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2505 Samaritan Dr, Suite 304, San Jose, CA, 95124
- NPI first listed
- 2008-02-06
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 244 N Jackson Ave Ste 203, San Jose, CA, 95116